Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry

Fig. 1

Selection of eligible patients from the CorEvitas RA registry who initiated treatment between January 2010 and December 2019. *Laboratory monitoring is not mandated in this observational registry; see the “Methods” section. CRP, C-reactive protein; Hb, hemoglobin; IL-6Ri, interleukin-6 receptor inhibitor; JAKi, Janus kinase inhibitor; RA, rheumatoid arthritis; TNFi, tumor necrosis factor inhibitor

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us